Lifecore Biomedical (NASDAQ:LFCR) Stock, Quote.Headers.trade-ideas

Lifecore Biomedical

Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers differentiated capabilities in the development, filling, and finishing of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid. Lifecore recognizes revenue in two different product categories, CDMO and fermentation.

Earnings

News

Penny Stocks

Eurozone

Commodities

Small Cap

Global

Intraday Update

Markets

Trading Ideas

AQST

ETAO

LFCR

TRUG

XTLB

U.S. stocks traded higher toward the end of trading, after the Federal Reserve left rates unchanged.

The Dow traded up 0.91% to 39,467.76 while the NASDAQ rose 1.08% to 16,341.42. The S&amp;P 500 also rose, gaining, 0.78% to 5,218.70.

Dow Surges 350 Points; Fed Holds Rates Steady

Movers

ADVM

AISP

ANGH

ANVS

ATER

ATXS

BCAN

BLDE

BNRG

BNTX

CETX

CMAX

DWAC

EGIO

HROW

IREN

MARA

MNTS

OBLG

OTRK

SEEL

SKIN

SRAD

SWVL

TSHA

WORX

WULF

Shares of  Lifecore Biomedical, Inc.  (NASDAQ: LFCR) fell sharply during Wednesday’s session after the company announced it concluded its strategic evaluation process, announced management succession and board changes.

Lifecore Biomedical shares dipped 31.7% to $4.91 on Wednesday.

Why Lifecore Biomedical Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday&#39;s Mid-Day Session

U.S. stocks traded mostly flat midway through trading, ahead of interest-rate decision from the Federal Reserve.

The Dow traded up 0.03% to 39,123.89 while the NASDAQ fell 0.01% to 16,165.15. The S&amp;P 500 also rose, gaining, 0.01% to 5,178.79.

Crude Oil Dips 2%; Signet Jewelers Shares Spike Higher

Lifecore Biomedical Inc

Today, the U.S. Food and Drug Administration authorized the first over-the-counter (OTC) hearing aid software device, Hearing Aid Feature, intended to be used with compatible versions of the Apple AirPods Pro headphones. Once installed and customized to the user's hearing needs, the Hearing Aid Feature enables compatible versions of the AirPods Pro to serve as an OTC hearing aid, intended to amplify sounds for individuals 18 years or older with perceived mild to moderate hearing impairment.
"Hearing loss is a significant public health issue impacting millions of Americans," said Michelle Tarver, M.D., Ph.D., acting director of the FDA's Center for Devices and Radiological Health.&nbsp;"Today's marketing authorization of an over-the-counter hearing aid software on a widely used consumer audio product is another step that advances the availability, accessibility and acceptability of hearing support for adults with perceived mild to moderate hearing loss."
More than 30 million American adults report some degree of hearing loss.&nbsp;Hearing loss can be caused by aging, exposure to loud noises, certain medical conditions, and other factors. Hearing loss can have a negative effect on communication, relationships, school or work performance and emotional well-being. Using hearing aids has been <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4253485-1&amp;h=3658607187&amp;u=https%3A%2F%2Fwww.federalregister.gov%2Fdocuments%2F2022%2F08%2F17%2F2022-17230%2Fmedical-devices-ear-nose-and-throat-devices-establishing-over-the-counter-hearing-aids%23p-666&amp;a=linked">linked</a> to reductions in the frequency or severity of cognitive decline, depression and other health problems in older adults.&nbsp;
The <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4253485-1&amp;h=229452156&amp;u=https%3A%2F%2Fweb.archive.org%2Fweb%2F20221028042729%2Fhttps%3A%2Fwww.fda.gov%2Fnews-events%2Fpress-announcements%2Ffda-finalizes-historic-rule-enabling-access-over-counter-hearing-aids-millions-americans&amp;a=FDA%27s+OTC+hearing+aid+regulations">FDA's OTC hearing aid regulations</a>&nbsp;established in October 2022 represented a significant step toward helping ensure that adults with mild to moderate hearing loss have improved access to more safe and effective product options. The rule enabled consumers with perceived mild to moderate hearing impairment to purchase hearing aids directly from stores or online retailers without the need for a medical exam, prescription or seeing an audiologist. Today's authorization exemplifies the FDA's continued commitment to provide safe and effective solutions for those with hearing loss, while also fostering innovation and convenience.
The Hearing Aid Feature (HAF) is a software-only mobile medical application that is intended to be used with compatible versions of the AirPods Pro. The HAF utilizes a self-fitting strategy, and users may adjust it to meet their hearing needs without the assistance of a hearing professional. The HAF is set up using an iOS device (e.g., iPhone, iPad), and the user's hearing levels are accessed from the iOS HealthKit to customize the HAF. Users can refine the volume, tone and balance settings after setting up the HAF.
The HAF was evaluated in a clinical study with 118 subjects with perceived mild to moderate hearing loss, at multiple U.S. sites. The results demonstrated that subjects who used the HAF self-fitting strategy achieved similar perceived benefit as subjects who received professional fitting of the same device. Results also showed comparable performance for tests measuring levels of amplification in the ear canal, as well as a measure of speech understanding in noise. No adverse events related to the device were observed in this study.
This application was reviewed under the FDA's&nbsp;<a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4253485-1&amp;h=2478959766&amp;u=https%3A%2F%2Fwww.fda.gov%2Fmedical-devices%2Fpremarket-submissions-selecting-and-preparing-correct-submission%2Fde-novo-classification-request&amp;a=De+Novo+premarket+review+pathway">De Novo premarket review pathway</a>, a regulatory pathway for some low- to moderate-risk devices that are novel and for which there is no prior legally marketed device.
As part of the Center for Devices and Radiological Health's strategic priority to advance health equity, the Center will continue to support innovation that expands access to important technologies and brings health care directly to patients.
The FDA granted marketing authorization&nbsp;of the Hearing Aid Feature to Apple Inc.

AAPL

FDA Authorizes First Over-The-Counter Hearing Aid Software, Intended To Be Used With Compatible Versions Of The Apple AirPods Pro Headphones

UBS analyst Timothy Arcuri maintains KLA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KLAC#NASDAQ">KLAC</a>) with a Neutral and lowers the price target from $900 to $765.

Price Target

Analyst Ratings

KLAC

UBS Maintains Neutral on KLA, Lowers Price Target to $765

Outlook:
Looking ahead, Banle remains focused on expanding its market presence, particularly in the biofuel sector, and continuing to enhance its global supply network. The Company is committed to driving operational efficiency and delivering sustainable growth in the face of ongoing macroeconomic challenges.

Guidance

BANL

CBL International Says "Looking Ahead, Banle Remains Focused On Expanding Its Market Presence, Particularly In The Biofuel Sector, And Continuing To Enhance Its Global Supply Network; Committed To Driving Operational Efficiency And Delivering Sustainable Growth In The Face Of Ongoing Macroeconomic Challenges"

General Mills, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GIS#NYSE">GIS</a>) announced that it has signed definitive agreements to sell its North American yogurt business to Lactalis and Sodiaal, leading<a target="_blank" href="https://www.benzinga.com/pressreleases/24/09/b40829103/general-mills-announces-agreements-to-sell-its-north-american-yogurt-business-to-lactalis-and-sodi" rel="noreferrer noopener"> French dairy companies, for a total of $2.1 billion.</a>
Under the agreements, Lactalis will acquire the U.S. yogurt business, while Sodiaal will take over the Canadian yogurt business. The transactions are anticipated to be completed by 2025, pending regulatory approvals and other standard closing conditions.
General Mills expects the combined transactions to be about 3 percent dilutive to adjusted earnings per share in the first year post-close, excluding transaction costs and one-time impacts. The company plans to use the net proceeds from the sales for share repurchases.
In a May <a target="_blank" href="https://www.bloomberg.com/news/articles/2024-09-12/general-mills-said-in-talks-for-2-billion-sale-of-north-america-yogurt-business?srnd=phx-deals&amp;sref=TBDibEcD" rel="noreferrer noopener">note</a>, Bloomberg Intelligence analysts Jennifer Bartashus and Jibril Lawal cited increased competition from Danone (OTC:<a class="ticker" href="https://www.benzinga.com/stock/DANOY#OTC">DANOY</a>) and Chobani Inc., coupled with limited market penetration, as factors prompting discussions about exiting the U.S. yogurt market.
Also Read:<a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/24/08/40321537/packaged-food-sector-to-see-mixed-performance-amid-economic-headwinds-goldman-sachs" rel="noreferrer noopener"> Packaged Food Sector To See Mixed Performance Amid Economic Headwinds: Goldman Sachs</a>
General Mills is also turning its portfolio to growth elements such as premium pet food and organic snacks, the report added.
In 2021, General Mills transferred its European Yoplait operations to Sodiaal in exchange for the Canadian business and reduced royalty rates for the Yoplait and Liberte brands in the U.S. and Canada.
According to Bartashus and Lawal, General Mills&#8217; U.S. retail yogurt business alone generated $1.4 billion in sales in the 12 months leading up to May 19, with Yoplait making up 87% of that total, Bloomberg added.
General Mills plans to provide additional details about the potential financial impact of the transactions when it reports&nbsp;its <a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">first-quarter&nbsp;results on September 18, 2024.</a>
According to&nbsp;<a target="_blank" href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw" rel="noreferrer noopener">Benzinga Pro</a>, GIS stock has gained over 10% in the past year. Investors can gain exposure to the stock via Invesco Food &amp; Beverage ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PBJ#NYSE">PBJ</a>) and&nbsp;First Trust Nasdaq Food &amp; Beverage ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTXG#NASDAQ">FTXG</a>).
Price Action: GIS shares are trading lower by 0.88% to $72.48 at last check Thursday.
Image via Shutterstock
Also Read:<a target="_blank" href="https://www.benzinga.com/news/earnings/24/09/40828733/nasdaq-s-p-500-set-for-modest-gains-as-investors-eye-august-inflation-data-and-ecb-rate-decision" rel="noreferrer noopener">&nbsp;</a>
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/09/40828733/nasdaq-s-p-500-set-for-modest-gains-as-investors-eye-august-inflation-data-and-ecb-rate-decision" target="_blank" rel="noreferrer noopener">Nasdaq, S&amp;P 500 Set For Modest Gains As Investors Eye August Inflation Data And ECB Rate Decision</a></li>
</ul>

Equities

Asset Sales

Media

DANOY

FTXG

General Mills Offloads US, Canadian Yogurt Divisions In $2.1B Deal Amid Competition And Market Challenges: Details

HNRA

HNR Acquisition Corp Rolls Out Advanced Automation Techniques In Permian Basin To Enhance Operational Efficiencies And Boost Oil Production; Pilot Testing Single Application For Field Operations And Reducing OPEX, With Plans To Expand Automation And Increase Well Output

UBS analyst Jay Sole maintains Designer Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DBI#NYSE">DBI</a>) with a Neutral and lowers the price target from $9 to $5.5.

UBS Maintains Neutral on Designer Brands, Lowers Price Target to $5.5

CBL International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BANL#NASDAQ">BANL</a>) reported $227.23 million in sales this quarter. This is a 18.38 percent increase over sales of $191.96 million the same period last year.

CBL International H1 Sales $227.23M Up From $191.96M YoY

UBS analyst Timothy Arcuri maintains Applied Mat (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMAT#NASDAQ">AMAT</a>) with a Neutral and lowers the price target from $220 to $210.

AMAT

UBS Maintains Neutral on Applied Mat, Lowers Price Target to $210

When <a href="https://www.benzinga.com/topic/shaquille-o-neal">Shaquille O&#8217;Neal</a> was searching for a home in Los Angeles after joining the Lakers, he made one of the most impulsive real estate decisions ever. Instead of spending time checking out the house's details, Shaq was sold by one piece of information: it was right across the street from pop star Paula Abdul's house.
Don't Miss:
<ul>
<li>Warren Buffett once said, "If you don't find a way to make money while you sleep, you will work until you die." <a href="https://www.benzinga.com/money/connect-invest-real-estate-notes">These high-yield real estate notes that pay 7.5% &#8211; 9% make earning passive income easier than ever.</a></li>
</ul>
In an <a href="https://youtu.be/dfCuZ6Ph_ao?si=dLNAFlZLqSJ0GNP6&amp;t=845">interview</a>, Shaq recounted how it all went down. He was house hunting in L.A., and while he wasn't particularly impressed with the home he was looking at, the real estate agent mentioned something that sealed the deal instantly. "Paula Abdul lives across the street," the agent said. Without a second thought, Shaq responded, "I'll take it!" He didn't even bother to look inside before making his decision.
Trending: A billion-dollar investment strategy with minimums as low as $10 — <a href="https://www.benzinga.com/money/fundrise-flagship-fund">you can become part of the next big real estate boom today.</a>
At the time, Paula Abdul, a former Laker Girl turned pop sensation, was one of the biggest names in entertainment. She and Shaq shared the same business manager and were friends. But despite Shaq's admitted admiration, they never dated. Instead, they became friendly neighbors.
Paula has fun memories of living across the street from the NBA legend. She <a href="https://www.youtube.com/watch?v=RTAIYjDJvRU">joked</a> about how <a href="https://www.benzinga.com/general/entertainment/24/09/40758484/nba-legend-shaq-shows-off-his-new-widebody-carbon-fiber-tesla-cybertruck-elon-musk-has-a-on">Shaq's many cars</a> took up all the space on the street, sometimes forcing her to move them just to get out of her own driveway. She even had to stand on her tiptoes to drive <a href="https://www.benzinga.com/general/entertainment/24/08/40413674/nba-legend-shaq-missed-his-tesla-cybertruck-so-much-instead-of-shipping-it-from-vegas-to-at">his massive vehicles</a>.
See Also: These five entrepreneurs are worth $223 billion –<a href="https://www.benzinga.com/money/arrived-homes-private-credit-fund">they all believe in one platform that offers a 7-9% target yield with monthly dividends</a>
"I didn&#8217;t know [he] came with like 18 billion cars," she recalled. "I had to get the keypad code, so I could go and get his car keys and move his cars," she continued.
His pet turtles also frequently escaped and wandered into her yard. They&#8217;d end up in her koi pond, and "his mom Lucille would come and visit, she&#8217;d be chasing them with a frying pan outside yelling at him."
But one of the most memorable moments came on New Year's Eve, when Shaq showed up at Paula's house in a flashy pink pinstripe suit, complete with a matching hat. He hoisted her over his shoulder and brought her to his party, even though she was still in sweats. Knowing Shaq's infamous midnight tradition – mooning everyone at the party – Paula cleverly hid under the dining room table to avoid being part of his antics.
Trending: This billion-dollar fund has invested in the next big real estate boom, <a href="https://www.benzinga.com/money/fundrise-flagship-fund">here's how you can join for $10.</a>
While their time as neighbors brought plenty of laughs and entertaining stories, it's clear that Shaq's decision to buy a house simply because it was near Paula Abdul is one for the books. Sometimes, when you know, you just know – even if you haven't stepped inside yet!
Read Next:
<ul>
<li>This Jeff Bezos-backed startup will allow you to<a href="https://www.benzinga.com/money/bezos-landlord-100-dollars"> become a landlord in just 10 minutes, and you only need $100</a>.</li>
<li>If there was a new fund backed by Jeff Bezos offering a 7-9% target yield with monthly dividends<a href="https://www.benzinga.com/money/arrived-private-credit-fund"> would you invest in it</a>?</li>
</ul>

Real Estate

'Do You Want To Look Inside? No, I'll Take It' – Shaq Bought A House On The Spot Because It Was Right Across From Paula Abdul's

Franklin Resources, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ben#NYSE">BEN</a>) reported its preliminary assets under management of $1.68 trillion as of Aug. 31, 2024. This reflected an increase of 1.1% from the prior month&#39;s level.
The improvement in AUM balance was due to the impact of positive markets, partially offset by long-term net outflows. Outflows included $7.7 billion of long-term net outflows at Western Asset Management. As previously revealed, the Macro Opportunities strategy, included in Alternative AUM, is closing and had $1.1 billion of AUM as of Aug. 31, 2024, and $0.9 billion of net outflows in the month.
<h2>Break Down of BEN&#39;s AUM Based on Asset Class</h2>
BEN recorded equity assets of $603.7 billion, which rose 2.5% from the previous month. Further, fixed income AUM of $574.5 billion at the end of August 2024 increased marginally from the prior month. Likewise, Multi-asset AUM was $172.9 billion, growing modestly from July 2024.
On the other hand, Alternative AUM decreased 1.5% to $251.2 billion from the prior month&#39;s level. Alternative AUM in the reported month includes a $2 billion reduction related to the reclassification of assets under administration.
The cash management balance was $64.35 billion, up 4.6% from the previous month.
<h2>Our Viewpoint on BEN</h2>
Franklin&#39;s efforts to diversify business through buyouts, solid AUM balance and a strong distribution platform will aid its top line. However, elevated expenses and volatility in investment management fees, which bring in the majority of its revenues, are near-term concerns.
Over the past three months, shares of BEN have plunged 11.5% against the industry&#39;s 3.8% rise.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/4d/77484.jpg?v=1359146759" />
Image Source: Zacks Investment Research
Currently, BEN carries a Zacks Rank #3 (Hold).
<h2>Performance of Other Asset Managers</h2>
Cohen &amp; Steers, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cns#NYSE">CNS</a>) reported a preliminary AUM of $88.1 billion as of Aug. 31, 2024. This reflected a rise of 4.1% from the prior month&#39;s level.
The increase in CNS&#39; AUM balance was driven by the market appreciation of $3.7 billion and net inflows of $8 billion, partially offset by distributions of $152 million.
Invesco (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ivz#NYSE">IVZ</a>) reported a preliminary month-end AUM of $1.75 trillion in August 2024. This represented a 1.1% increase from the previous month.
IVZ reported net long-term inflows of $2.4 billion in August. Non-management fee-earning net inflows were $0.9 billion, while money market net outflows totaled $6.4 billion. Further, Invesco&#39;s AUM was favorably impacted by solid market returns, which boosted its AUM by $16 billion. Further, FX increased the AUM balance by $7.3 billion.
<a href="https://www.zacks.com/stock/news/2335231/franklin-s-august-aum-balance-improves-on-favorable-markets?cid=CS-BENZ-FT-analyst_blog|company_news_finance_sector-2335231">To read this article on Zacks.com click here.</a>

Large Cap

Mid Cap

Management

Franklin's August AUM Balance Improves on Favorable Markets

<a href="https://www.bloomberg.com/news/articles/2024-09-12/gm-in-talks-to-buy-chinese-batteries-made-in-us-by-japan-s-tdk?srnd=homepage-americas" title="https://www.bloomberg.com/news/articles/2024-09-12/gm-in-talks-to-buy-chinese-batteries-made-in-us-by-japan-s-tdk?srnd=homepage-americas">https://www.bloomberg.com/news/articles/2024-09-12/gm-in-talks-to-buy-chinese-batteries-made-in-us-by-japan-s-tdk?srnd=homepage-americas</a>.

TTDKY

'GM In Talks To Buy Chinese Batteries Made In U.S. By Japan's TDK' - Bloomberg News

UBS analyst Michael Goldsmith maintains UDR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UDR#NYSE">UDR</a>) with a Buy and raises the price target from $48 to $52.

UBS Maintains Buy on UDR, Raises Price Target to $52

As the digital asset market faces uncertainty ahead of the <a href="https://www.benzinga.com/topic/2024-presidential-election">2024 U.S. presidential election</a>, many wonder how potential leadership changes could impact the industry&#8217;s future. 
With regulatory clarity on the horizon, companies are preparing for possible shifts that could bolster or challenge crypto&#8217;s growth. However, one expert maintains a straightforward approach: &#8220;We&#8217;re just focused on building the best tech.&#8221;
Polygon Labs, a prominent player in blockchain technology, will participate in the upcoming <a href="https://www.benzinga.com/digital-assets">Benzinga Future of Digital Assets event</a>, where it will address the market's challenges and opportunities. During a recent interview, Colin Butler, global head of institutional capital at Polygon Labs, shared insights into how their company approaches these uncertainties.
<h3 class="wp-block-heading">Staying Focused Despite Potential Political Changes</h3>
With the U.S. presidential election around the corner, concerns about changes in federal policy on digital assets are widespread. However, Butler emphasized that Polygon's approach will remain consistent no matter which administration comes into power. 
"As we build software for the decentralized marketplace, our strategy will be the same regardless of administration—we&#8217;re just focused on building the best tech," Butler said. While he acknowledged that more favorable regulations could benefit the industry, the company's long-term vision is centered on continuing to enhance its technology.
<h3 class="wp-block-heading">Barriers to Consumer Adoption in Crypto</h3>
Although large amounts of capital have been funneled into the digital asset market, widespread consumer use of crypto applications has yet to materialize. According to Butler, two main issues are hindering broader adoption—current rules and the complexity of user interfaces. "Right now, Web3&#8217;s UI is very poor," he noted, adding that while promising efforts are being made, the issue has not been fully addressed.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/digital-assets"><img loading="lazy" decoding="async" width="300" height="250" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/11183059/905735A6-57D3-4874-9AA1-75D037842DB3-1-2.gif" alt="" class="wp-image-543330" /></a></figure>
Polygon Labs, though primarily focused on infrastructure rather than consumer-facing applications, is taking steps to improve this by developing the Aggregation Layer. This layer aims to streamline cross-chain interoperability, making the Web3 experience easier and more accessible, similar to what users experience with Web2 technology.
<h3 class="wp-block-heading">Preparing for Market Volatility</h3>
The volatility in digital asset markets has led many companies to reassess their strategies. Butler explained that Polygon has taken steps to adjust to the past year&#8217;s challenges. "Since the bear market first hit over a year ago, Polygon has right-sized itself to handle a long crypto winter," he said. By cutting costs and focusing on critical projects, the company is positioning itself to continue moving forward even during uncertain times.
<h3 class="wp-block-heading">Looking Toward the Future</h3>
As Butler prepares to speak at the upcoming <a href="https://www.benzinga.com/digital-assets">Benzinga Future of Digital Assets </a>event, his insights emphasize Polygon Labs' commitment to technological advancement and readiness to face future market challenges. By focusing on delivering robust infrastructure and adapting to an ever-changing environment, Polygon is setting the stage for continued leadership in the digital asset space.
<hr class="wp-block-separator has-alpha-channel-opacity" />
As the digital asset market continues to mature, the convergence of regulatory shifts, M&amp;A activities, and adoption trends will define the future of this dynamic field. <a href="https://www.benzinga.com/digital-assets">Benzinga's Future of Digital Assets</a> event in New York City this November will provide industry leaders and investors a platform to explore these developments further, offering insights into the evolving regulatory environment and the latest market dynamics.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Events

What Can Clear Crypto's Biggest Hurdles? Expert Says, 'We're Just Focused On Building The Best Tech'

Cantor Fitzgerald analyst Kristen Kluska downgrades Fulcrum Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FULC#NASDAQ">FULC</a>) from Overweight to Neutral.

Downgrades

FULC

Cantor Fitzgerald Downgrades Fulcrum Therapeutics to Neutral

Medical Properties Trust, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MPW#NYSE">MPW</a>) shares are trading higher on Thursday, after the medical REIT disclosed a global settlement with tenant Steward Health Care System, its secured lenders, and the <a href="https://www.benzinga.com/pressreleases/24/09/b40823182/medical-properties-trust-takes-control-of-its-real-estate-from-steward-health-care" target="_blank" rel="noreferrer noopener">Unsecured Creditors Committee</a>.
The settlement, announced on Wednesday, covers 23 hospitals previously managed by Steward, with 15 hospitals in Arizona, Florida, Louisiana, Ohio, and Texas already leased to new tenants.
The agreement restores the company&#8217;s control over its real estate, ends its relationship with Steward, and allows for the immediate transition of operations at 15 hospitals to new, high-quality operators.
Effective Sept. 11, the new operators will assume responsibility for operating revenue and expenses at the hospitals, managing them for Steward on an interim basis until purchase agreements are finalized.
Medical Properties Trust anticipates receiving annual cash rental payments of about $160 million from the new leases, based on a $2 billion lease base, once stabilized by Q4 2026.
The amount represents roughly 95% of the rent Steward would have owed, including minimum annual escalators. The leases have a weighted average initial term of about 18 years.
The company stated that no cash rent payments will be required for the 15 properties for the rest of 2024 to facilitate the re-tenanting and minimize patient care disruption.
Also Read: <a href="https://www.benzinga.com/government/24/09/40831961/european-central-bank-cuts-key-interest-rates-as-inflation-cools">European Central Bank Cuts Key Interest Rates As Inflation Cools</a>
Payments are expected to start in Q1 2025, reach about 50% of fully stabilized rent by the end of 2025, and achieve full stabilization by Q4 2026.
Medical Properties Trust stated, &#8220;We believe this global settlement is a positive outcome for all stakeholders. By replacing Steward, we are better positioned to protect the critical function of these facilities for the benefit of their communities and the value of our real estate for the benefit of our shareholders.&#8221;
Apart from this, the company is also negotiating solutions for its Norwood, Massachusetts and Texarkana, Texas construction projects, as well as four hospitals closed before Steward&#8217;s bankruptcy and two recently closed or uncertain facilities. These six properties have an aggregate lease base of about $300 million.
As per the agreement, Medical Properties Trust has agreed to sell three &#8220;Space Coast&#8221; Florida hospitals to Orlando Health, with proceeds mainly going to Steward.
Steward will forfeit claims on other hospitals in the portfolio as of Sept.11.
A Bankruptcy Court hearing on Sept. 17 will consider final approval, pending completion of Steward&#8217;s sales and regulatory approvals.
Notably, in May, Steward Health Care plunged into Chapter 11 bankruptcy, posing significant financial risks for hospitals across eight states and Medical Properties Trust approved the funding of $75 million in debtor-in-<a href="https://www.benzinga.com/news/24/05/38672521/us-healthcare-landlord-medical-properties-trusts-largest-tenant-steward-health-goes-bankrupt-sparks" target="_blank" rel="noreferrer noopener">possession financing to the company</a>.
As of June 30, Medical Properties Trust&#8217;s cash and cash equivalent <a target="_blank" href="https://www.benzinga.com/pressreleases/24/08/b40249847/medical-properties-trust-inc-reports-second-quarter-results" rel="noreferrer noopener">stood at $606.6 million</a>.
Price Action: MPW shares are up 8.7% at $5.24 at last check Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/economics/macro-economic-events/24/09/40831982/producer-inflation-slows-to-1-7-yearly-in-august-jobless-claims-align-with-expect#google_vignette">Producer Inflation Slows To 1.7% Yearly In August, Jobless Claims Align With Expectations</a></li>
</ul>
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo: Dolores M. Harvey/Shutterstock.com

Contracts

Why REIT Medical Properties Trust Shares Are Surging On Thursday?

North Central Florida Hospice, Inc. and Haven Medical Group, LLC (collectively "Haven Hospice"), a Florida-based company for comprehensive hospice care services in 18 counties in north central Florida completed its sale of select assets to BrightSpring Health Services (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTSG#NASDAQ">BTSG</a>), a leading provider of home and community-based health services for complex populations, effective September 1, 2024. Haven Hospice's Mission remains unchanged: "Honoring life by providing comfort, care and compassion to individuals and families we serve."&nbsp;In a separate but related transaction, BrightSpring also acquired the Attic Resale Stores.

BTSG

BrightSpring Health Services Acquires Haven Hospice; No Financial Terms Disclosed

Investors with a lot of money to spend have taken a bearish stance on Axon Enterprise (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AXON#NASDAQ">AXON</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with AXON, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 9 uncommon options trades for Axon Enterprise.
This isn't normal.
The overall sentiment of these big-money traders is split between 22% bullish and 55%, bearish.
Out of all of the special options we uncovered, 2 are puts, for a total amount of $67,640, and 7 are calls, for a total amount of $469,707.
<h3>Expected Price Movements</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $290.0 to $400.0 for Axon Enterprise during the past quarter. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Axon Enterprise's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Axon Enterprise's significant trades, within a strike price range of $290.0 to $400.0, over the past month.
<h3>Axon Enterprise Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1726154258_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th style="text-align: right;">Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>AXON</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>10/18/24</td>
<td>$13.2</td>
<td>$12.2</td>
<td>$12.8</td>
<td>$380.00</td>
<td>$128.0K</td>
<td style="text-align: right;">82</td>
<td style="text-align: right;">58</td>
</tr>
<tr>
<td>AXON</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>11/15/24</td>
<td>$20.8</td>
<td>$18.9</td>
<td>$18.9</td>
<td>$390.00</td>
<td>$103.9K</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">57</td>
</tr>
<tr>
<td>AXON</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>09/20/24</td>
<td>$13.0</td>
<td>$12.8</td>
<td>$12.8</td>
<td>$370.00</td>
<td>$91.0K</td>
<td style="text-align: right;">567</td>
<td style="text-align: right;">273</td>
</tr>
<tr>
<td>AXON</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$87.5</td>
<td>$83.8</td>
<td>$85.4</td>
<td>$350.00</td>
<td>$42.6K</td>
<td style="text-align: right;">101</td>
<td style="text-align: right;">5</td>
</tr>
<tr>
<td>AXON</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$4.1</td>
<td>$3.8</td>
<td>$3.8</td>
<td>$290.00</td>
<td>$36.1K</td>
<td style="text-align: right;">77</td>
<td style="text-align: right;">96</td>
</tr>
</tbody>
</table>

<h3>About Axon Enterprise</h3>
Axon Enterprise Inc develops, manufactures, and sells conducted energy devices and cloud-based digital evidence management software designed for use by law enforcement, corrections, military forces, private security personnel, and private individuals for personal defense. The company operates in two segments: Taser and software &amp; sensors. Taser develops and sells CEDs used for protecting users and virtual reality training. Software and sensors manufacture fully integrated hardware and cloud-based software solutions such as body cameras, automated license plate reading, and digital evidence management systems. Axon delivers its products worldwide and derives the majority of its revenue from the software &amp; sensors segment and geographically from the United States.
<h3>Where Is Axon Enterprise Standing Right Now?</h3>
<ul>
<li>With a volume of 386,945, the price of AXON is up 4.8% at $379.08. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 54 days.</li>
</ul>
<h3>What Analysts Are Saying About Axon Enterprise</h3>
A total of 2 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $387.5.
<ul>
<li>An analyst from JMP Securities downgraded its action to Market Outperform with a price target of $375. </li>
<li>An analyst from Baird persists with their Outperform rating on Axon Enterprise, maintaining a target price of $400. </li>
</ul>
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Axon Enterprise, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

Options

AXON

A Closer Look at Axon Enterprise's Options Market Dynamics

Financial giants have made a conspicuous bearish move on Dollar Tree. Our analysis of options history for Dollar Tree (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DLTR#NASDAQ">DLTR</a>) revealed 12 unusual trades.
Delving into the details, we found 33% of traders were bullish, while 66% showed bearish tendencies. Out of all the trades we spotted, 6 were puts, with a value of $191,250, and 6 were calls, valued at $730,630.
<h3>Expected Price Movements</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $65.0 to $95.0 for Dollar Tree during the past quarter. 
<h3>Volume &amp; Open Interest Development</h3>
In today's trading context, the average open interest for options of Dollar Tree stands at 662.89, with a total volume reaching 2,449.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Dollar Tree, situated within the strike price corridor from $65.0 to $95.0, throughout the last 30 days.
<h3>Dollar Tree Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1726154254_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>DLTR</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$6.0</td>
<td>$5.8</td>
<td>$5.81</td>
<td>$80.00</td>
<td>$551.9K</td>
<td>355</td>
<td style="text-align: right;">950</td>
</tr>
<tr>
<td>DLTR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>10/18/24</td>
<td>$6.65</td>
<td>$6.6</td>
<td>$6.65</td>
<td>$65.00</td>
<td>$46.5K</td>
<td>1.0K</td>
<td style="text-align: right;">262</td>
</tr>
<tr>
<td>DLTR</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$5.15</td>
<td>$5.0</td>
<td>$5.1</td>
<td>$65.00</td>
<td>$41.8K</td>
<td>513</td>
<td style="text-align: right;">324</td>
</tr>
<tr>
<td>DLTR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$4.9</td>
<td>$4.75</td>
<td>$4.8</td>
<td>$80.00</td>
<td>$40.8K</td>
<td>186</td>
<td style="text-align: right;">38</td>
</tr>
<tr>
<td>DLTR</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/20/24</td>
<td>$4.0</td>
<td>$3.1</td>
<td>$4.0</td>
<td>$65.00</td>
<td>$40.0K</td>
<td>2.0K</td>
<td style="text-align: right;">200</td>
</tr>
</tbody>
</table>

<h3>About Dollar Tree</h3>
Dollar Tree operates discount stores across the United States and Canada, with over 8,600 shops under its namesake banner and nearly 7,800 under Family Dollar. About 47% of Dollar Tree's sales in fiscal 2023 were composed of consumables (including food, health and beauty, and cleaning products), around 45% from variety items (including toys and homewares), and over 5% from seasonal items. The Dollar Tree banner sells most of its merchandise at the $1.25 price point and positions its stores in well-populated suburban markets. Conversely, Family Dollar primarily sells consumable merchandise (80% of the banner's sales) at prices below $10. About two-thirds of Family Dollar's stores are located in urban and suburban markets, with the remaining one-third located in rural areas.
<h3>Where Is Dollar Tree Standing Right Now?</h3>
<ul>
<li>With a volume of 1,254,855, the price of DLTR is up 4.72% at $69.72. </li>
<li>RSI indicators hint that the underlying stock may be approaching oversold.</li>
<li>Next earnings are expected to be released in 76 days.</li>
</ul>
<h3>What The Experts Say On Dollar Tree</h3>
In the last month, 5 experts released ratings on this stock with an average target price of $86.6.
<ul>
<li>Consistent in their evaluation, an analyst from Telsey Advisory Group keeps a Outperform rating on Dollar Tree with a target price of $95. </li>
<li>An analyst from Morgan Stanley has decided to maintain their Equal-Weight rating on Dollar Tree, which currently sits at a price target of $80. </li>
<li>In a cautious move, an analyst from BMO Capital downgraded its rating to Market Perform, setting a price target of $68. </li>
<li>An analyst from Wells Fargo has decided to maintain their Overweight rating on Dollar Tree, which currently sits at a price target of $100. </li>
<li>An analyst from Goldman Sachs has decided to maintain their Buy rating on Dollar Tree, which currently sits at a price target of $90. </li>
</ul>
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Dollar Tree options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

DLTR

Dollar Tree Unusual Options Activity For September 12

Whales with a lot of money to spend have taken a noticeably bearish stance on First Solar.
Looking at options history for First Solar (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FSLR#NASDAQ">FSLR</a>) we detected 9 trades.
If we consider the specifics of each trade, it is accurate to state that 33% of the investors opened trades with bullish expectations and 55% with bearish.
From the overall spotted trades, 3 are puts, for a total amount of $187,095 and 6, calls, for a total amount of $330,758.
<h3>What's The Price Target?</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $210.0 to $280.0 for First Solar over the last 3 months. 
<h3>Volume &amp; Open Interest Development</h3>
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for First Solar's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of First Solar's whale trades within a strike price range from $210.0 to $280.0 in the last 30 days. 
<h3>First Solar Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1726154249_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th style="text-align: right;">Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>FSLR</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>10/25/24</td>
<td>$4.75</td>
<td>$3.15</td>
<td>$4.25</td>
<td>$280.00</td>
<td>$106.2K</td>
<td style="text-align: right;">300</td>
<td style="text-align: right;">50</td>
</tr>
<tr>
<td>FSLR</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$17.4</td>
<td>$16.4</td>
<td>$17.05</td>
<td>$210.00</td>
<td>$85.2K</td>
<td style="text-align: right;">110</td>
<td style="text-align: right;">54</td>
</tr>
<tr>
<td>FSLR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$26.85</td>
<td>$25.3</td>
<td>$25.6</td>
<td>$250.00</td>
<td>$74.3K</td>
<td style="text-align: right;">616</td>
<td style="text-align: right;">34</td>
</tr>
<tr>
<td>FSLR</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$28.15</td>
<td>$28.1</td>
<td>$28.1</td>
<td>$240.00</td>
<td>$53.3K</td>
<td style="text-align: right;">270</td>
<td style="text-align: right;">70</td>
</tr>
<tr>
<td>FSLR</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>11/15/24</td>
<td>$44.05</td>
<td>$43.4</td>
<td>$44.05</td>
<td>$270.00</td>
<td>$48.4K</td>
<td style="text-align: right;">151</td>
<td style="text-align: right;">11</td>
</tr>
</tbody>
</table>

<h3>About First Solar</h3>
First Solar designs and manufactures solar photovoltaic panels, modules, and systems for use in utility-scale development projects. The company's solar modules use cadmium telluride to convert sunlight into electricity. This is commonly called thin-film technology. First Solar is the world's largest thin-film solar module manufacturer. It has production lines in Vietnam, Malaysia, the United States, and India.
<h3>Current Position of First Solar</h3>
<ul>
<li>Trading volume stands at 988,423, with FSLR's price down by -1.21%, positioned at $236.94.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 47 days.</li>
</ul>
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for First Solar with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

FSLR

Smart Money Is Betting Big In FSLR Options

Brookline Capital analyst Kemp Dolliver downgrades Oncternal Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONCT#NASDAQ">ONCT</a>) from Buy to Hold.

ONCT

Brookline Capital Downgrades Oncternal Therapeutics to Hold

Enzo Biochem: Is This Time Finally Different?

Laughing Water Capital Q2 2024 Letter

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Lifecore Biomedical (NASDAQ:<a href="https://investorplace.com/stock-quotes/lfcr-stock-quote/">LFCR</a>) just reported results for the second quarter of 2024.<ul><li>Lifecore Biomedical reported earnings per share of 39 cents. This was above the analyst estimate for EPS of -7 cents.</li><li>The company reported revenue of $30.15 million.</li><li>This was 1.31% better than the analyst estimate for revenue of $29.76 million.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/lfcr-stock-earnings-lifecore-biomedical-for-q2-of-2024/">LFCR Stock Earnings: Lifecore Biomedical Beats EPS, Beats Revenue for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

LFCR Stock Earnings: Lifecore Biomedical Beats EPS, Beats Revenue for Q2 2024

Lifecore Biomedical (LFCR) has issued an announcement. At the company's Annual Meeting, shareholders made several key decisions regarding the board...

Lifecore Biomedical Shareholders Decide on Corporate Governance

Lifecore Biomedical reports Q4 results; initiates FY25 outlook

Lifecore Biomedical, Inc. (LFCR) Q4 2024 Earnings Conference Call Transcript

In a report released today, Michael Petusky from Barrington assigned a Hold rating to Lifecore Biomedical (LFCR – Research Report). The company's s...

Lifecore Biomedical (LFCR) Receives a Hold from Barrington

Lifecore CFO John Morberg to depart, Ryan Lake to succeed

The latest announcement is out from Lifecore Biomedical (LFCR). Ryan D. Lake has been appointed as the new Chief Financial Officer and Secretary of...

Lifecore Biomedical Welcomes Ryan Lake as New CFO

Lifecore Biomedical regains Nasdaq compliance

BRKR

BVHMF

BVHMY

CDMO

CTLP

ERIC

HALO

THRY

XPOF

Press Releases

LFCR Investors Have Opportunity to Lead Lifecore Biomedical, Inc. Securities Fraud Lawsuit

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Lifecore Biomedical, Inc. of Class Action Lawsuit and Upcoming Deadlines - LFCR

Legal

LIFECORE BIOMEDICAL, INC. (NASDAQ: LFCR) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Lifecore Biomedical, Inc. Investors of Upcoming Deadline

Lifecore Biomedical Appoints Brikkelle Thompson as Senior Vice President of Human Resources

LFCR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Lifecore Biomedical, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Lifecore, Spire Global, Oddity Tech, and Arbor Realty and Encourages Investors to Contact the Firm

Lead Plaintiff Deadline Quickly Approaching in Lifecore Biomedical, Inc. (LFCR) Class Action – Shareholders Should Contact Robbins LLP for Information

Lifecore Biomedical Regains Compliance with Nasdaq Listing Requirements

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lifecore

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

Lifecore Biomedical

Lifecore Biomedical (LFCR) Forecast

Lifecore Biomedical (NASDAQ:LFCR) Stock, Quote.Headers.trade-ideas